IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
Part of paid clinical trials in Waltham, Massachusetts.
- Sponsor
- Accelerated Cure Project for Multiple Sclerosis
- Study ID
- NCT02486562
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Accepted
Study Details
iConquerMS™ is a research initiative developed by and for people with multiple sclerosis (MS) to contribute their health data and ideas to advance and accelerate research into MS. iConquerMS welcomes adults with MS and others interested in advancing MS research, children and teens with MS and their family members (via iConquerMS Kids \& Teens) and MS caregivers (via iConquerMS Caregivers) to participate.
Key Dates
- Start date
- Nov 30, 2014
- Status verified
- Feb 2025
- Primary completion
- Oct 31, 2030
- Completion
- Oct 31, 2036
Study Design
- Enrollment
- 20,000 participants (estimated)
Arms
- Arm: People diagnosed with Multiple Sclerosis
Primary Outcome Measure
Number of people with multiple sclerosis who experience health-related quality-of-life changes [ Time Frame: 1 year ]
Central Contacts
- Sara Loud, MSEE, MBA781-487-0032
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Accelerated Cure Project | Waltham | Massachusetts | 02451 |
Find similar trials in Waltham, MA
By condition
By specialty
By research site
Related Studies
- Genes and Environment in Multiple SclerosisRecruiting · Columbia University · Bethesda, Maryland
- PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric DiseasesPHASE1/PHASE2 · Recruiting · Brigham and Women's Hospital · Boston, Massachusetts
- Molecular Imaging of NET Using [C-11]MRB-PET in MSPHASE1/PHASE2 · Recruiting · Brigham and Women's Hospital · Boston, Massachusetts
- CorEvitas Multiple Sclerosis (MS) RegistryEnrolling By Invitation · CorEvitas · Waltham, Massachusetts